Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.

Mr. Hermanus  Kieftenbeld

Interim Chief Executive Officer, Chief Financial Officer & Chief Admin. Officer

Ms. Annie  Tsong

Chief Product & Technology Strategy Officer

Mr. John G. Melo

Pres, Chief Executive Officer & Director

Chief Financial Officer & Chief Admin. Officer

Mr. Charles  Kraft

Senior Vice President of Global Manufacturing & Process Devel.

Ms. Nicole  Kelsey

Chief Legal Officer & Sec.

Ms. Caroline  Hadfield

Pres of Aprinnova

Sunil  Chandran

Chief Science Officer and Head of R&D

Mr. Eduardo  Alvarez

Chief Operating Officer

Ms. Elizabeth E. Dreyer CPA

Chief Accounting Officer & Corporation Controller

Mr. Peter  DeNardo

Senior Director of Investor Relations & Corporation Communications

Ms. Doris  Choi

Gen. Counsel & Sec.

Ms. Christine  Ofori

Chief People Officer

Mr. Jim  Iacoponi

Senior Vice President of Nutrition Ingredients

Ms. Beth  Baker Bannerman

Chief Engagement & Sustainability Officer

Ms. Daya  Fields

Pres of Pipette & Purecane

Amyris, Inc.

Amyris, Inc. Estrutura de gestão

Informação de gestão